{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001652130","name":"Intellia Therapeutics, Inc.","summary":"Intellia Therapeutics is a biopharmaceutical company focused on CRISPR-based gene editing therapies. Its lead product candidates are lonvoguran ziclumeran (lonvo-z, NTLA-2002) for hereditary angioedema and nexiguran ziclumeran (nex-z, NTLA-2001) for transthyretin amyloidosis, both in Phase 3 development. The company leverages proprietary CRISPR, lipid nanoparticle (LNP), and oligonucleotide technologies to develop in vivo genome editing treatments administered as a single IV infusion, with a planned commercial launch of lonvo-z in the first half of 2027.","people":[],"products":[{"name":"Lonvoguran ziclumeran (lonvo-z, NTLA-2002)","type":"platform","description":"Investigational in vivo CRISPR-based therapeutic targeting KLKB1 gene to reduce kallikrein levels and prevent hereditary angioedema attacks via one-time IV infusion."},{"name":"Nexiguran ziclumeran (nex-z, NTLA-2001)","type":"platform","description":"Investigational in vivo CRISPR-based therapeutic targeting TTR gene for treatment of ATTR amyloidosis with cardiomyopathy and polyneuropathy via one-time IV infusion."}],"partnerships":[{"partner_name":"Regeneron Pharmaceuticals, Inc.","partnership_type":"development","description":"Collaboration focused on the development of product candidates leveraging Intellia's CRISPR and related technologies.","start_date":null}],"affiliations":[],"origin":{"leaf":"ce6713ffdf4cc83c498d5e752d4da9047ac298a0c7f88b103e68a91b6c5fa6ea","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"96ff4c300f0749ca0e383e96fa4b8e8c2724ef45a231833f5c9ca4db3b1ed19e","parent":"ca039493a3c673734b5e34357580ce1ca8020ac9748462fd61d45d3cd5c01e43","source":"0001193125-26-076550","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}